Association of polymorphic markers of the <i>XRCC1</i>, <i>ERCC5</i>, <i>TP53</i>, <i>CDKN1A1</i> genes with the survival of patients after platinum-based chemotherapy for triple negative breast cancer

Association of polymorphic markers of the <i>XRCC1</i>, <i>ERCC5</i>, <i>TP53</i>, <i>CDKN1A1</i> genes with the survival of patients after platinum-based chemotherapy for triple negative breast cancer

Background. Breast cancer is the most common cancer among women. Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, in which there are no special targets for therapy. Therefore chemotherapy is still leading treatment for TNBC including the regiments with platinum d...

Full description

Saved in:
Bibliographic Details
Main Authors: T. M. Zavarykina, P. K. Lomskova, M. A. Kapralova, O. O. Gordeeva, I. P. Ganshina, D. S. Khodyrev, S. V. Khokhlova, I. V. Kolyadina
Format: Article
Language:Russian
Published: ABV-press 2023-05-01
Series:Опухоли женской репродуктивной системы
Subjects:
triple negative breast cancer
platinum-based chemotherapy
polymorphic marker
<i>xrcc1</i> gene
<i>ercc5</i>
<i>tp53</i>
<i>cdkn1a</i>
<i>brca1/2</i> mutations
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/1055
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items